CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer.
Gut
; 70(5): 890-899, 2021 05.
Article
in En
| MEDLINE
| ID: mdl-32816920
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Peptide Fragments
/
Pyridinium Compounds
/
Adenocarcinoma
/
Interferon-gamma
/
Cyclic N-Oxides
/
Carcinoma, Pancreatic Ductal
/
Immune Checkpoint Inhibitors
/
Indolizines
Limits:
Animals
/
Humans
Language:
En
Journal:
Gut
Year:
2021
Type:
Article
Affiliation country:
China